Status:
COMPLETED
Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced Walk
Lead Sponsor:
University Hospitals Cleveland Medical Center
Collaborating Sponsors:
Pfizer
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
45-85 years
Phase:
PHASE4
Brief Summary
A paced 20-minute walk is a reproducible model for acute pain in knee osteoarthritis
Detailed Description
This is a randomizd, placbo-controlled, crossover trial comparing a single dose of celecoxib to placebo measuring the time to onset of acute pain in a paced 20-minute walk. 40 subjects will be enroll...
Eligibility Criteria
Inclusion
- Knee osteoarthritis by ACR clinical criteria Pain of at least 40 mm by VAS at baseline
- \-
Exclusion
- Non-pregant, non-lactating Able to stop active arthritis medication for washout Cardiovascular risk factors Abnormal EKG -
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2005
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00194090
Start Date
June 1 2004
End Date
September 1 2005
Last Update
August 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospitals of Cleveland
Cleveland, Ohio, United States, 44106